No3(4) 2021
Back to the issue
|
DOI 10.37219/2528-8253-2021-3-82 |
Kosakovskyi A.
Evaluation of efficiency and safety of apicold mint nose spray for allergic
rhinitis |
Kosakovsky Anatoly L.
Shupyk National Healthcare University of Ukraine
Head of Department of Pediatric Otorhinolaryngology, Audiology, Phoniatrics
Doctor of Medical Sciences, Professor
E-mail: akosakovskyi@gmail.com
ORCID ID: 0000-0001-7194-420X |
|
Abstract
Introduction: Allergic rhinitis affects 10 to 40% of the population,
and among children the incidence is 2-25%.
Aim: Evaluation of the effectiveness and safety of "Apicold Mint"
nasal spray in children and adults with allergic rhinitis.
Material and methods: The effect of "Apicold Mint" Nasal Spray
(manufactured by APIPHARMA doo) was studied in 45 patients with allergic
rhinitis. The clinical study involved 21 (47%) children aged 4 to 18 years
and 24 (53%) adults.
Results and discussion: The use of the drug "Apicold Mint" nasal
spray helps to reduce the symptoms of allergic rhinitis and eliminates the
feeling of dryness, which often occurs with the use of topical
corticosteroids and decongestants. In addition, the use of the drug "Apicold
Mint" nasal spray significantly reduced the need for vasoconstrictor drops,
which is also positive in the treatment of patients with allergic rhinitis.
Conclusion: Appointment of the drug "Apicold Mint" nasal spray in the
complex therapy of allergic rhinitis contributes to a faster reduction of
symptoms and increases the effectiveness of local drugs. |
|
Keywords
"Apicold mint" nasal spray, menthol, globules of eucalyptus oil, allergic
rhinitis, children, adults. |
|
Reference
- Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group;
World Health Organization. Allergic rhinitis and its impact on asthma. J
Allergy Clin Immunol. 2001;108(5 Suppl):S147-334. doi:
10.1067/mai.2001.118891.
- Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK,
et al. Worldwide time trends in the prevalence of symptoms of asthma,
allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One
and Three repeat multcountry cross-sectional surveys. Lancet. 2006;368
(9537):733-43. doi: 10.1016/S0140-6736(06)69283-0.
- Zabolotko VM, Kosakovskiy AL, Rudenko NG, Rudenko OV.
Otolaryngological care for children 0-17 years old inclusive, under
supervision in health care institutions in the sphere of management of
the Ministry of Health of Ukraine for 2016. Center for Health
Statistics, Ministry of health of Ukraine, 2017. 156 с.
- Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, et al.
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines – 2016
revision. J Allergy Clin Immunol. 2017;140(4):950-958. doi:
10.1016/j.jaci.2017.03.050.
- Yurochko F, Kosakovsky A, Shkorbotun V, ed. [Pediatric rhinology].
Study guide. Lviv: MC, 2020. 288 p. [In Ukrainian].
- https://apipharma.hr/hr/o-nama
- https://compendium.com.ua/dec/340349/
|
|
